Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
NCT00001373
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study is designed to explore the genetics and pathophysiology of diseases presenting with intermittent fever, including familial Mediterranean fever, TRAPS, hyper-IgD syndrome, and related diseases. The following individuals may be eligible for this natural history study: 1) patients with known or suspected familial Mediterranean fever, TRAPS, hyper-IgD syndrome or related disorders; 2) relatives of these patients; 3) healthy, normal volunteers 7 years of age or older. Patients will undergo a medical and family history, physical examination, blood and urine tests.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Familial Mediterranean Fever (FMF)
- Autoinflammation
- Periodic Fever
- Fever
- Genetic Diseases
- ROSAH
- ALPK1
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 2 months to 115 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Last updated on ClinicalTrials.gov
- October 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- National Institutes of Health Clinical Center · Bethesda, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.